Wuxi Biologics Cayman Inc. buy hmaurer
Start price
24.05.20
/
50%
€5.03
Target price
04.11.21
€6.67
Performance (%)
116.44%
End price
28.02.21
€10.89
Summary
This prediction ended on 28.02.21 with a price of €10.89. The BUY prediction by hmaurer for Wuxi Biologics Cayman Inc. saw massive gains of 116.44%. hmaurer has 50% into this predictionWuxi Biologics is a China-based company that provides biological research and development, testing, and manufacturing services for pharmaceutical companies worldwide. The company offers a wide range of services including integrated discovery and development services, clinical trial services, and commercial manufacturing of biologics. Wuxi Biologics has state-of-the-art facilities in China and the United States, and has established partnerships with leading global biopharmaceutical companies. The company's mission is to become the premier global biologics solutions provider, and it has been recognized for its innovation and excellence in the industry.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Wuxi Biologics Cayman Inc. | -5.367% | -5.367% | -71.922% | -87.926% |
| iShares Core DAX® | 1.051% | -1.833% | 12.822% | 15.392% |
| iShares Nasdaq 100 | -0.547% | -3.738% | 40.625% | 42.396% |
| iShares Nikkei 225® | -1.778% | -8.115% | 16.092% | 0.891% |
| iShares S&P 500 | 0.002% | -2.226% | 28.387% | 41.095% |
Comments by hmaurer for this prediction
In the thread Wuxi Biologics (cayman) Inc. diskutieren
Buy mit Kursziel 20,0